SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001213900-11-000447
Filing Date
2011-02-02
Accepted
2011-02-02 16:30:47
Documents
1
Period of Report
2011-01-31

Document Format Files

Seq Description Document Type Size
1 FORM 3 f3092310horgan_soligenix.html 3  
1 FORM 3 f3092310horgan_soligenix.xml 3 1511
  Complete submission text file 0001213900-11-000447.txt   3586
Mailing Address 29 EMMONS DRIVE SUITE C-10 PRINCETON NJ 08540
Business Address 29 EMMONS DRIVE SUITE C-10 PRINCETON NJ 08540 609-538-8200
SOLIGENIX, INC. (Issuer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O SOLIGENIX, INC. 29 EMMONS DRIVE, STE. C-10 PRINCETON NJ 08540
Business Address
HORGAN KEVIN (Reporting) CIK: 0001510614 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-16929 | Film No.: 11567018